Sellers Dorsey Managing Director, Suzanne Bierman, and Senior Director, Julie Cannariato, will speak alongside public health professionals in a webinar hosted by the Population Health Alliance (PHA) on February 25 at 3 PM (ET).
About the webinar:
Section 1115 waivers let states test new Medicaid models. Research demonstrates clear, positive benefits in several areas, including increased access, reduced hospital and emergency department visits, gains in food security, and more. Yet the future of Section 1115 waivers face several challenges including uneven quality limited long-term outcome data, and state capacity to manage complex reporting and analysis.
Plus, recent federal policy changes, including tighter CMS approval standards and new statutory budget-neutrality rules under H.R.1, raise the threshold for approval and renewal and may slow future waiver activity.
In this webinar, speakers will discuss:
- Key results reported in published 1115 waiver evaluations from 2015–2025
- Waiver areas with the strongest evidence for improved access and service use
- Where quality results have been inconsistent and where long-term outcomes remain limited
- Recent federal policy changes that affect waiver design and approval
- Future directions and opportunities
